Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy save search
Global Iron Deficiency Anemia Therapy Market Report 2024
Published: 2024-02-02 (Crawled : 04:00) - prnewswire.com
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
report anemia global therapy market
Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy
Published: 2024-02-01 (Crawled : 22:00) - prnewswire.com
NVRO | $12.745 2.04% 56K
|
Health Technology
|
| O: -1.45%
H: 1.36%
C: -4.18%
therapy diabetic
EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
Published: 2024-02-01 (Crawled : 13:00) - globenewswire.com
EDAP | $7.43 10K
|
Health Technology
|
| O: 1.2%
H: 0.0%
C: -5.79%
one treatment therapy study
Navigating the Challenges: Bringing Advanced Radiation Therapy Solutions to the Frontline
Published: 2024-01-31 (Crawled : 20:00) - accuray.com
ARAY | $2.255 -2.38% 120K
|
Health Technology
|
| O: 0.0%
H: 2.22%
C: -4.07%
solutions advanced therapy
Cadrenal Therapeutics Highlights Publication of Peer-Reviewed Article Supporting Need for New Anticoagulation Therapy for Patients with Certain Medical Conditions
Published: 2024-01-31 (Crawled : 15:30) - biospace.com/
CVKD G | $0.391 -3.46% 68K
|
|
| O: -1.79%
H: 12.12%
C: 10.3%
publication medical therapeutics therapy
Jaguar Gene Therapy Announces FDA Clearance of IND to Study JAG201 in a Genetic Form of Autism Spectrum Disorder and Phelan-McDermid Syndrome
Published: 2024-01-31 (Crawled : 15:00) - biospace.com/
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: 0.84%
H: 2.02%
C: -0.73%
jag201 fda genetic clearance therapy study
Phio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
Published: 2024-01-31 (Crawled : 13:00) - globenewswire.com
PHIO | $0.6656 2.3K
|
Health Technology
|
| O: 2.25%
H: 15.0%
C: -1.0%
cell pharmaceuticals therapy
Kite Receives U.S. FDA Approval of Manufacturing Process Change Resulting in Reduced Median Turnaround Time for Yescarta® CAR T-cell Therapy
Published: 2024-01-30 (Crawled : 15:00) - biospace.com/
GILD | $67.64 -0.16% 1.2M
|
Health Technology
|
| O: -0.34%
H: 0.13%
C: -0.23%
yescarta fda t-cell change approval therapy
Understanding the Types of Therapy for Children
Published: 2024-01-29 (Crawled : 23:00) - lifestance.com
FNCTF | $11.128 580
|
Communications
| Email alert
Add to watchlist
children therapy
Takeda’s HYQVIA® Approved by European Commission as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Published: 2024-01-29 (Crawled : 11:00) - biospace.com/
TAK | $13.235 0.42% 710K
|
Health Technology
|
| O: 0.38%
H: 0.78%
C: 0.78%
hyqvia approved therapy
Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Disease-Free Survival (DFS) as Adjuvant Therapy Versus Observation in High-Risk Patients With Localized Muscle-Invasive and Locally Advanced Urothelial Carcinoma After Surgery
Published: 2024-01-26 (Crawled : 23:00) - biospace.com/
MRK | $125.715 -0.38% 1.4M
|
Health Technology
|
| O: 0.32%
H: 0.42%
C: 0.26%
keytruda advanced therapy
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Abecma (idecabtagene vicleucel) in Earlier Lines of Therapy for Triple-Class Exposed Relapsed and Refractory Multiple Myeloma
Published: 2024-01-26 (Crawled : 15:30) - biospace.com/
BMY | $48.365 -0.3% 4.9M
|
Health Technology
|
| O: 0.71%
H: 0.48%
C: -0.52%
chmp positive cell therapy
Ultragenyx Announces Completion of Dosing Across Stage 1 Cohorts in Pivotal Phase 1/2/3 Cyprus2+ Study Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease
Published: 2024-01-25 (Crawled : 21:00) - globenewswire.com
RARE | $43.94 2.5% 230K
|
Health Technology
|
| O: 0.55%
H: 1.01%
C: -1.16%
ux701 disease treatment therapy study
Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid Tumors
Published: 2024-01-25 (Crawled : 14:00) - globenewswire.com
ELTX | $9.33 1.08% 21K
|
|
| O: 1.52%
H: 19.1%
C: 14.93%
tumors publication cell preclinical therapeutics therapy
ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo
Published: 2024-01-24 (Crawled : 21:00) - globenewswire.com
CLPT | $5.7 1.6% 45K
|
Health Technology
|
| O: 0.84%
H: 0.28%
C: -1.67%
prism installation first health system laser therapy
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE A | $25.84 -0.27% 8.9M
|
Health Technology
|
| O: 0.39%
H: 0.82%
C: -0.74%
NVS | $93.29 -1.19% 530K
|
Health Technology
|
| O: 0.22%
H: 0.43%
C: -0.39%
GILD | $67.64 -0.16% 1.2M
|
Health Technology
|
| O: 0.1%
H: 0.43%
C: -0.04%
AUTL | $4.94 0.82% 210K
|
Health Technology
|
| O: -0.91%
H: 11.52%
C: 4.94%
drug report t-cell global therapy market
Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases
Published: 2024-01-24 (Crawled : 10:00) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
rare acquisition global therapy
CAR T-Cell Therapy Market to Register Stunning Growth During the Study Period (2019-2032) | DelveInsight
Published: 2024-01-23 (Crawled : 22:00) - prnewswire.com
ACLX | $55.65 -2.3% 170K
|
|
| O: 1.59%
H: 1.14%
C: -1.42%
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: 0.61%
H: 1.52%
C: 0.03%
PSTX | $2.065 -15.02% 940K
|
Health Technology
|
| O: 1.57%
H: 4.94%
C: 1.54%
INCY | $53.88 0.84% 230K
|
Health Technology
|
| O: 0.29%
H: 0.15%
C: -1.95%
BEAM | $25.79 0.35% 530K
|
Health Technology
|
| O: 1.88%
H: 0.88%
C: -2.79%
t-cell therapy growth study market
Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at the Association for Research in Otolaryngology 2024 MidWinter Meeting
Published: 2024-01-23 (Crawled : 17:00) - prnewswire.com
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: -0.51%
H: 0.37%
C: 0.32%
genetic association positive research meeting trial therapy
Children's Hospital of Philadelphia Performs First in U.S. Gene Therapy Procedure to Treat Genetic Hearing Loss
Published: 2024-01-23 (Crawled : 17:00) - prnewswire.com
LLY | $745.04 -0.76% 730K
|
Health Technology
|
| O: -0.51%
H: 0.37%
C: 0.32%
first genetic hospital treat therapy
Gainers vs Losers
| 52% | 48% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.